References
Kaempf JW, Wu YX, Kaempf AJ, Kaempf AM, Wang L, Grunkemeier G et al. What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants? J Perinatol 2012; 32: 344–348.
Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001; 344 (26): 1966–1972.
O'Rourke DJ, El-Khuffash A, Moody C, Walsh K, Molloy EJ . Patent ductus arteriosus evaluation by serial echocardiography in preterm infants. Acta Paediatr 2008; 97 (5): 574–578.
Yanowitz TD, Baker RW, Sobchak Brozanski B . Prophylactic indomethacin reduces grades III and IV intraventricular hemorrhages when compared to early indomethacin treatment of a patent ductus arteriosus. J Perinatol 2003; 23 (4): 317–322.
Kluckow M, Evans N . Low superior vena cava flow and intraventricular haemorrhage in preterm infants. Arch Dis Child Fetal Neonatal Ed 2000; 82 (3): F188–F194.
De Buyst J, Rakza T, Pennaforte T, Johansson AB, Storme L . Hemodynamic effects of fluid restriction in preterm infants with significant patent ductus arteriosus. J Pediatr 2012, e-pub ahead of print 24 April 2012 doi:10.1016/j.jpeds.2012.03.012.
Bose CL, Laughon MM . Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed 2007; 92 (6): F498–F502.
Benitz WE . Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol 2010; 30 (4): 241–252.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McNamara, P., Jain, A. Patent ductus arteriosus treatment in preterm infants—time to consider shunt volume?. J Perinatol 33, 248–249 (2013). https://doi.org/10.1038/jp.2012.104
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2012.104
- Springer Nature America, Inc.